{"certainAgreement":{"piSponsorEmployee":false,"restrictiveAgreement":false},"limitationsAndCaveats":{"description":"This study was terminated early due to safety concerns from the previously untreated CLL experience. All participants who remained on study at that time were permanently removed from protocol therapy. The median time on protocol therapy was 1 cycle"},"pointOfContact":{"email":"jorgej_castillo@dfci.harvard.edu","organization":"Dana-Farber Cancer Institute","phone":"617-632-6045","title":"Jorge J. Castillo"}}